Highlights Glomus tumors are rare neoplasms that aris­e from neuromyoarterial canal or glomus body. In the GI tract, stomach is the most common site for Glomus tumors. Symptoms usually are non specific and can be discovered incidentally during upper GI endoscopy. Immunohistochemistry stains after surgical excision or tissue biopsy can confirm the diagnosis. Surgical treatment is the preferred option for GGTs and long-term follow-up is required due to high metastatic and recurrence rate in the malignant type.

The 17th case of acute lumbar paraspinal compartment syndrome in the scientific/medical literature was presented in this study. We then review all 17 cases for demographic and clinical characteristics, in particular in terms of how they influence ultimate outcomes. All but one case occurred in a male, and most patients were less than age 40 (71%). Symptoms typically were precipitated by some athletic activity (59%), other causes were surgery (n = 4), drug abuse (n = 2), and direct trauma (n =1). Peak CPK values ranged from 5000 to 350,000 U/L. Ten patients ultimately achieved or were presumed to achieve full recovery, six had persistent low back pain several months later and one remained in renal failure. The only predictor of final outcome was the treatment given, with six of seven who underwent surgical fasciotomy and both patients administered hyperbaric oxygen experiencing full recovery, versus just two of seven treated conservatively (p = 0.03).

Non-alcoholic fatty liver disease is the most prevalent liver disease with a global prevalence of 25%. The frequency of non-alcoholic fatty liver disease and the percentage of people with severe liver disease are expected to rise given the ongoing obesity pandemic, the rise in diabetes, and other factors. This will have a significant effect on health care expenditure and the need for liver transplantation, for which non-alcoholic steatohepatitis is already on track to overtake alcoholic steatohepatitis as the most prevalent reason. Non-alcoholic fatty liver disease is characterized by the triglyceride accumulation in the cytoplasm of hepatocytes. Patients with non-alcoholic fatty liver disease who have advanced fibrosis and non-alcoholic steatohepatitis are at much higher risk of negative outcomes, such as overall mortality and liver-specific morbidity and death. It is a multisystemic clinical illness entity that manifests extrahepatic conditions like polycystic ovarian syndrome, type 2 diabetes, chronic renal disease, hypothyroidism, and psoriasis. In fact, cardiovascular disease, cancer, and liver-related problems are the three leading causes of death in non-alcoholic fatty liver disease patients, in that order. Non-alcoholic fatty liver disease is further divided into two subtypes hepatic steatosis and non-alcoholic steatohepatitis ranging from milder to more aggressive form of the disease.